Evaluation of thiol-based antioxidant therapeutics in cystic fibrosis sputum: Focus on myeloperoxidase

References

• Davis PB, Drumm M, Konstan MW. Cystic fibrosis. Amer J Respir Crit Care Med 1996;154:1229–1256.
   PubMed Web of Science ®Google Scholar
• Anderson MP, Gregory RJ, Thompson S, Souza DW, Paul S, Mulligan RC, Smith AE, Welsh MJ. Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science 1991;253:202–205.
   PubMed Web of Science ®Google Scholar
• Donaldson SH, Boucher RC. Sodium channels and cystic fibrosis. Chest 2007;132:1631–1636.
   Google Scholar
• Tummler B, Puchelle E. CFTR:a multifaceted epithelial molecule. Trends Cell Biol 1997;7:250–251.
   Google Scholar
• Wine JJ. The genesis of cystic fibrosis lung disease. J Clin Invest 1999;103:309–312.
   PubMed Web of Science ®Google Scholar
• de Rose V. Mechanisms and markers of airway inflammation in cystic fibrosis. Eur Respir J 2002;19:333–340.
   PubMed Web of Science ®Google Scholar
• Meyer KC. Neutrophils, myeloperoxidase, and bronchiectasis in cystic fibrosis: green is not good. J Lab Clin Med 2004; 144:124–126.
   PubMed Web of Science ®Google Scholar
• Schultz J, Kaminker K. Myeloperoxidase of the leucocyte of normal human blood. I. Content and localization. Arch Biochem Biophys 1962; 96:465–467.
   PubMed Web of Science ®Google Scholar
• Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998;391:393–397.
   PubMed Web of Science ®Google Scholar
• Hazen SL, Hsu FF, Gaut JP, Crowley JR, Heinecke JW. Modification of proteins and lipids by myeloperoxidase. Methods Enzymol 1999;300:88–105.
   PubMed Web of Science ®Google Scholar
• Hawkins CL. The role of hypothiocyanous acid (HOSCN) in biological systems. Free Radic Res 2009;43:1147–1158.
   PubMed Web of Science ®Google Scholar
• Regelmann WE, Siefferman CM, Herron JM, Elliott GR, Clawson CC, Gray BH. Sputum peroxidase activity correlates with the severity of lung disease in cystic fibrosis. Pediatr Pulmonol 1995;19:1–9.
   PubMed Web of Science ®Google Scholar
• Van Der Vliet A, Nguyen MN, Shigenaga MK, Eiserich JP, Marelich GP, Cross CE. Myeloperoxidase and protein oxidation in cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 2000;279:537–546.
   PubMed Web of Science ®Google Scholar
• Cantin AM. Taurine modulation of hypochlorous acid-induced lung epithelial cell injury in vitro. Role of anion transport. J Clin Invest 1994;93:606–614.
   Google Scholar
• Bishop C, Hudson VM, Hilton SC, Wilde C. A pilot study of the effect of inhaled buffered reduced glutathione on the clinical status of patients with cystic fibrosis. Chest 2005; 127:308–317.
   PubMed Web of Science ®Google Scholar
• Griese M, Ramakers J, Krasselt A, Starosta V, Van Koningsbruggen S, Fischer R, Ratjen F, Mullinger B, Huber RM, Maier K, Rietschel E, Scheuch G. Improvement of alveolar glutathione and lung function but not oxidative state in cystic fibrosis. Am J Respir Crit Care Med 2004;169:822–828.
   PubMed Web of Science ®Google Scholar
• Hartl D, Starosta V, Maier K, Beck-Speier I, Rebhan C, Becker BF, Latzin P, Fischer R, Ratjen F, Huber RM, Rietschel E, Krauss-Etschmann S, Griese M. Inhaled glutathione decreases PGE2 and increases lymphocytes in cystic fibrosis lungs. Free Radic Biol Med 2005;39:463–472.
   PubMed Web of Science ®Google Scholar
• Jaques A, Daviskas E, Turton JA, McKay K, Cooper P, Stirling RG, Robertson CF, Bye PT, Lesouef PN, Shadbolt B, Anderson SD, Charlton B. Inhaled mannitol improves lung function in cystic fibrosis. Chest 2008;133:1388–1396.
   PubMed Web of Science ®Google Scholar
• Nash EF, Stephenson A, Ratjen F, Tullis E. Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis. Cochrane Database Syst Rev 2009;CD007168.
   Google Scholar
• Roum JH, Borok Z, McElvaney NG, Grimes GJ, Bokser AD, Buhl R, Crystal RG. Glutathione aerosol suppresses lung epithelial surface inflammatory cell-derived oxidants in cystic fibrosis. J Appl Physiol 1999;87:438–443.
   PubMed Web of Science ®Google Scholar
• Tirouvanziam R, Conrad CK, Bottiglieri T, Herzenberg LA, Moss RB. High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis. Proc Natl Acad Sci USA 2006;103:4628–4633.
   PubMed Web of Science ®Google Scholar
• Visca A, Bishop CT, Hilton SC, Hudson VM. Improvement in clinical markers in CF patients using a reduced glutathione regimen: qn uncontrolled, observational study. J Cyst Fibros 2008;Volume 7:433–436.
   Google Scholar
• de Oliveira-Marques V, Cyrne L, Marinho HS, Antunes F. A quantitative study of NF-kappa B activation by H2O2: relevance in inflammation and synergy with TNF-alpha. J Immunol 2007;178:3893–3902.
   PubMed Web of Science ®Google Scholar
• Thomas EL, Jefferson MM, Joyner RE, Cook GS, King CC. Leukocyte myeloperoxidase and salivary lactoperoxidase: identification and quantitation in human mixed saliva. J Dent Res 1994;73:544–555.
   PubMed Web of Science ®Google Scholar
• Chapman AL, Morrissey BM, Vasu VT, Juarez MM, Houghton JS, Li CS, Cross CE, Eiserich JP. Myeloperoxidase-dependent oxidative metabolism of nitric oxide in the cystic fibrosis airway. J Cyst Fibros 2010;9:84–92.
   Google Scholar
• Dypbukt JM, Bishop C, Brooks WM, Thong B, Eriksson H, Kettle AJ. A sensitive and selective assay for chloramine production by myeloperoxidase. Free Radic Biol Med 2005;39: 1468–1477.
   PubMedGoogle Scholar
• Yankaskas JR, Haizlip JE, Conrad M, Koval D, Lazarowski E, Paradiso AM, Rinehart CA, Jr, Sarkadi B, Schlegel R, Boucher RC. Papilloma virus immortalized tracheal epithelial cells retain a well-differentiated phenotype. Am J Physiol 1993;264: 1219–1230.
   Google Scholar
• Hayden MS, Ghosh S. Shared principles in NF-kappa B signaling. Cell 2008;132:344–362.
   PubMed Web of Science ®Google Scholar
• Kohlhoff SA, Kohler E, Sollich V. Serum myeloperoxidase in cystic fibrosis patients receiving systemic antibiotics. Scand J Infect Dis 2007;39:163–166.
   PubMed Web of Science ®Google Scholar
• Ordonez CL, Kartashov AI, Wohl ME. Variability of markers of inflammation and infection in induced sputum in children with cystic fibrosis. J Pediatr 2004;145:689–692.
   PubMedGoogle Scholar
• Kaul N, Forman HJ. Activation of NF kappa B by the respiratory burst of macrophages. Free Radic Biol Med 1996;21: 401–405.
   PubMed Web of Science ®Google Scholar
• Kaul N, Choi J, Forman HJ. Transmembrane redox signaling activates NF-kappa B in macrophages. Free Radic Biol Med 1998;24:202–207.
   PubMed Web of Science ®Google Scholar
• Staal FJ, Roederer M, Herzenberg LA. Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. Proc Natl Acad Sci USA 1990;87:9943–9947.
   PubMed Web of Science ®Google Scholar
• Smith JW, Colombo JL, McDonald TL. Comparison of serum amyloid A and C-reactive protein as indicators of lung inflammation in corticosteroid treated and non-corticosteroid treated cystic fibrosis patients. J Clin Lab Anal 1992;6:219–224.
   Web of Science ®Google Scholar
• Levy H, Kalish LA, Huntington I, Weller N, Gerard C, Silverman EK, Celedon JC, Pier GB, Weiss ST. Inflammatory markers of lung disease in adult patients with cystic fibrosis. Pediatr Pulmonol 2007;42:256–262.
   PubMed Web of Science ®Google Scholar
• Mohammed JR, Mohammed BS, Pawluk LJ, Bucci DM, Baker NR, Davis WB. Purification and cytotoxic potential of myeloperoxidase in cystic fibrosis sputum. J Lab Clin Med 1988;112:711–720.
   PubMed Web of Science ®Google Scholar
• Brown RK, Wyatt H, Price JF, Kelly FJ. Pulmonary dysfunction in cystic fibrosis is associated with oxidative stress. Eur Respir J 1996;9:334–339.
   PubMed Web of Science ®Google Scholar
• Dominguez C, Gartner S, Linan S, Cobos N, Moreno A. Enhanced oxidative damage in cystic fibrosis patients. Biofactors 1998;8:149–153.
   PubMedGoogle Scholar
• Starosta V, Rietschel E, Paul K, Baumann U, Griese M. Oxidative changes of bronchoalveolar proteins in cystic fibrosis. Chest 2006;129:431–437.
   PubMedGoogle Scholar
• Kim JS, Okamoto K, Rubin BK. Pulmonary function is negatively correlated with sputum inflammatory markers and cough clearability in subjects with cystic fibrosis but not those with chronic bronchitis. Chest 2006;129:1148–1154.
   PubMed Web of Science ®Google Scholar
• Reynolds WF, Sermet-Gaudelus I, Gausson V, Feuillet MN, Bonnefont JP, Lenoir G, Descamps-Latscha B, Witko-Sarsat V. Myeloperoxidase promoter polymorphism -463G is associated with more severe clinical expression of cystic fibrosis pulmonary disease. Mediators Inflamm 2006;2006: 36735.
   PubMed Web of Science ®Google Scholar
• Cantin AM, White TB, Cross CE, Forman HJ, Sokol RJ, Borowitz D. Antioxidants in cystic fibrosis. Conclusions from the CF antioxidant workshop, Bethesda, Maryland, 11-12 November 2003. Free Radic Biol Med 2007;42:15–31.
   Google Scholar
• Downey DG, Bell SC, Elborn JS. Neutrophils in cystic fibrosis. Thorax 2009;64:81–88.
   PubMed Web of Science ®Google Scholar
• Cantin AM. Potential for antioxidant therapy of cystic fibrosis. Curr Opin Pulm Med 2004;10:531–536.
   PubMed Web of Science ®Google Scholar
• Thomas EL, Grisham MB, Jefferson MM. Myeloperoxidase-dependent effect of amines on functions of isolated neutrophils. J Clin Invest 1983;72:441–454.
   PubMed Web of Science ®Google Scholar
• Witko-Sarsat V, Delacourt C, Rabier D, Bardet J, Nguyen AT, Descamps-Latscha B. Neutrophil-derived long-lived oxidants in cystic fibrosis sputum. Am J Respir Crit Care Med 1995; 152:1910–1916.
   PubMedGoogle Scholar
• Witko-Sarsat V, Nguyen AT, Descamps-Latscha B. Immunomodulatory role of phagocyte-derived chloramines involving lymphocyte glutathione. Mediators Inflamm 1993; 2:235–241.
   Google Scholar
• Peskin AV, Winterbourn CC. Kinetics of the reactions of hypochlorous acid and amino acid chloramines with thiols, methionine, and ascorbate. Free Radic Biol Med 2001;30: 572–579.
   PubMed Web of Science ®Google Scholar
• Rahman I, Biswas SK, Jimenez LA, Torres M, Forman HJ. Glutathione, stress responses, and redox signaling in lung inflammation. Antioxid Redox Signal 2005;7:42–-59.
   PubMed Web of Science ®Google Scholar
• Midwinter RG, Cheah FC, Moskovitz J, Vissers MC, Winterbourn CC. IkappaB is a sensitive target for oxidation by cell-permeable chloramines: inhibition of NF-kappa B activity by glycine chloramine through methionine oxidation. Biochem J 2006;396:71–78.
   Web of Science ®Google Scholar
• Winterbourn CC, Metodiewa D. Reactivity of biologically important thiol compounds with superoxide and hydrogen peroxide. Free Radic Biol Med 2009;27:322–328.
   Google Scholar
• Bolscher BG, Wever R. A kinetic study of the reaction between human myeloperoxidase, hydroperoxides and cyanide. Inhibition by chloride and thiocyanate. Biochim Biophys Acta 1984;788:1–10.
   PubMed Web of Science ®Google Scholar
• Burner U, Jantschko W, Obinger C. Kinetics of oxidation of aliphatic and aromatic thiols by myeloperoxidase compounds I and II. FEBS Lett 1999;443:290–296.
   PubMed Web of Science ®Google Scholar
• Marquez LA, Dunford HB. Mechanism of the oxidation of 3,5,3′,5′-tetramethylbenzidine by myeloperoxidase determined by transient- and steady-state kinetics. Biochemistry 1997;6:9349–9355.
   Google Scholar
• Naumchik IV, Karasyova EI, Metelitza DI, Edimecheva IP, Sorokin VL, Shadyro OI. Inhibition of peroxidase-catalyzed oxidation of 3,3,5,5-tetramethylbenzidine by aminophenols. Biochemistry (Mosc) 2005;70:322–329.
   Google Scholar
• Karaseva EI, Losev Iu P, Metelitsa DI. [Inhibition of peroxidase oxidation of 3,3′,5,5′-tetramethylbenzidine and o-phenylenediamine by 1-amino-2-naphthol-4-sulfonic acid and its polysulfide]. Prikl Biokhim Mikrobiol 2001;37: 713–721.
   Google Scholar
• McGirr LG, O'Brien PJ. Glutathione conjugate formation without N-demethylation during the peroxidase catalysed N-oxidation of N,N',N,N'-tetramethylbenzidine. Chem Biol Interact 1987;61:61–74.
   Google Scholar
• Svensson BE, Graslund A, Strom G, Moldeus P. Thiols as peroxidase substrates. Free Radic Biol Med 1993;14:167–175.
   Google Scholar
• Turkall RM, Tsan MF. Oxidation of glutathione by the myeloperoxidase system. J Reticuloendothel Soc 1982;31: 353–360.
   Google Scholar
• Pommier J, Cahnmann HJ. Interaction of lactoperoxidase with thiols and diiodotyrosine. J Biol Chem 1979;254: 3006–3010.
   Google Scholar
• Hamza A, Tong M, AbdulHameed MD, Liu J, Goren AC, Tai HH, Zhan CG. Understanding microscopic binding of human microsomal prostaglandin E synthase-1 (mPGES-1) trimer with substrate PGH2 and cofactor GSH: insights from computational alanine scanning and site-directed mutagenesis. J Phys Chem B 2010;114:5605–5616.
   Google Scholar
• Kim JS, Hackley GH, Okamoto K, Rubin BK. Sputum processing for evaluation of inflammatory mediators. Pediatr Pulmonol 2001;32:152–158.
   PubMed Web of Science ®Google Scholar
• Blackwell TS, Stecenko AA, Christman JW. Dysregulated NF-kappa B activation in cystic fibrosis: evidence for a primary inflammatory disorder. Am J Physiol Lung Cell Mol Physiol 2001;281:69–70.
   PubMed Web of Science ®Google Scholar
• Schwarzer C, Fu Z, Fischer H, Machen TE. Redox-independent activation of NF-kappa B by Pseudomonas aeruginosa pyocyanin in a cystic fibrosis airway epithelial cell line. J Biol Chem 2008;283:27144–27153.
   Google Scholar
• Dauletbaev N, Rickmann J, Viel K, Diegel H, von Mallinckrodt C, Stein J, Wagner T. O, Bargon J. Antioxidant properties of cystic fibrosis sputum. Am J Physiol Lung Cell Mol Physiol 2005;288:903–909.
   Google Scholar